New perspectives for gene therapy in endocrinology

被引:16
作者
Barzon, L
Bonaguro, R
Palù, G
Boscaro, M
机构
[1] Univ Padua, Dept Med & Surg Sci, I-35128 Padua, Italy
[2] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy
关键词
D O I
10.1530/eje.0.1430447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy for endocrine diseases represents an exciting new type of molecular intervention that may be a curative one. Endocrine disorders that might be treated by gene therapy include monogenic diseases, such as GH deficiency and hypothalamic diabetes insipidus, and multifactorial diseases, such as diabetes mellitus, obesity and cancer. Premises seem promising for endocrine tumours, but many combined approaches of cell and gene therapy are foreseeable also for other endocrine disorders. This review outlines the principles of gene therapy, describes the endocrine disorders that might take advantage of gene transfer approaches, as well as the gene therapy interventions that have already been attempted, their major limitations and the problems that remain to be solved.
引用
收藏
页码:447 / 466
页数:20
相关论文
共 209 条
  • [41] SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE BY INJECTION OF GENETICALLY ENGINEERED MYOBLASTS
    DHAWAN, J
    PAN, LC
    PAVLATH, GK
    TRAVIS, MA
    LANCTOT, AM
    BLAU, HM
    [J]. SCIENCE, 1991, 254 (5037) : 1509 - 1512
  • [42] Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs
    Draghia-Akli, R
    Fiorotto, ML
    Hill, LA
    Malone, PB
    Deaver, DR
    Schwartz, RJ
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (12) : 1179 - 1183
  • [43] CONDITIONAL TRANSFORMATION OF A PANCREATIC BETA-CELL LINE DERIVED FROM TRANSGENIC MICE EXPRESSING A TETRACYCLINE-REGULATED ONCOGENE
    EFRAT, S
    FUSCODEMANE, D
    LEMBERG, H
    ALEMRAN, O
    WANG, XR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3576 - 3580
  • [44] DIRECT ARTERIAL VASCULARIZATION OF ESTROGEN-INDUCED PROLACTIN-SECRETING ANTERIOR-PITUITARY TUMORS
    ELIAS, KA
    WEINER, RI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14): : 4549 - 4553
  • [45] Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
    Evans, CH
    Mankin, HJ
    Ferguson, AB
    Robbins, PD
    Ghivizzani, SC
    Herndon, JH
    Kang, R
    Tomaino, MM
    Wright, TM
    [J]. HUMAN GENE THERAPY, 1996, 7 (10) : 1261 - 1280
  • [46] Fagin JA, 1996, CANCER RES, V56, P765
  • [47] FAGIN JA, 1993, J CLIN INVEST, V91, P1753
  • [48] Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin
    Falqui, L
    Martinenghi, S
    Severini, GM
    Corbella, P
    Taglietti, MV
    Arcelloni, C
    Sarugeri, E
    Monti, LD
    Paroni, R
    Dozio, N
    Pozza, G
    Bordignon, C
    [J]. HUMAN GENE THERAPY, 1999, 10 (11) : 1753 - 1762
  • [49] Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat
    Fan, LY
    Iseki, S
    [J]. ARCHIVES OF HISTOLOGY AND CYTOLOGY, 1998, 61 (01) : 17 - 28
  • [50] A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
    Fero, ML
    Rivkin, M
    Tasch, M
    Porter, P
    Carow, CE
    Firpo, E
    Polyak, K
    Tsai, LH
    Broudy, V
    Perlmutter, RM
    Kaushansky, K
    Roberts, JM
    [J]. CELL, 1996, 85 (05) : 733 - 744